A detailed history of Ameriprise Financial Inc transactions in 23and Me Holding Co. stock. As of the latest transaction made, Ameriprise Financial Inc holds 114,825 shares of ME stock, worth $438,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,825
Previous 112,225 2.32%
Holding current value
$438,631
Previous $43,000 6.98%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.29 - $0.51 $754 - $1,326
2,600 Added 2.32%
114,825 $40,000
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $33,760 - $76,804
84,400 Added 303.32%
112,225 $59,000
Q4 2023

Feb 14, 2024

BUY
$0.71 - $0.97 $12,352 - $16,876
17,398 Added 166.86%
27,825 $25,000
Q3 2023

Nov 14, 2023

SELL
$0.96 - $2.01 $116 - $243
-121 Reduced 1.15%
10,427 $10,000
Q2 2023

Aug 14, 2023

SELL
$1.59 - $2.29 $1,435 - $2,067
-903 Reduced 7.89%
10,548 $18,000
Q1 2023

May 15, 2023

BUY
$2.05 - $2.87 $23,474 - $32,864
11,451 New
11,451 $26,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.